|
 |
CALORIE
The page is no longer available. You may want to read the following pages.
WE Uber, JM Toole, MR Stroud, JS Haney... - ... and Cardiovascular ..., 2011 - AATS/WTSAObjective: Refractory bleeding after complex cardiovascular surgery often leads to increased
length of stay, cost, morbidity, and mortality. Recombinant activated factor VII administered in
the intensive care unit can reduce bleeding, transfusion, and surgical re-exploration. We ...
K Davison, RA Coutts... - Medicine & Science in Sports & ..., 2011 - PURPOSE: To determine the relationship between changes in ventilation and HRV during exercise and recovery. Method: Fifteen healthy male volunteers (245 yrs) performed a graded exercise test to 85% of age predicted max. HRV was processed as r MSSD of 30 ...
SM Shepard, S Tejman-Yarden, S Khanna... - Critical care ..., 2011 - Objective: Dexmedetomidine (DEX; Precedex) is an alpha-2 adrenergic receptor agonist that produces anxiolysis and sleep-like sedation without narcosis or respiratory depression and has relatively few cardiovascular side effects. Given its favorable sedative properties ...
Y Fukuta, IZ Yildiz-Aktas... - Scandinavian ..., 2012 - Legionella endocarditis is extremely uncommon, and embolic phenomena have never been reported. We report the first case of Legionella micdadei prosthetic valve endocarditis complicated by brain abscess. A 57-y-old immunocompromised woman with a history of ... [CITATION] Persistent fever in a multicomplicated infective endocarditis D Attias, C Bouleti... - Archives of Cardiovascular Diseases, 2012 - Elsevier
J Korewicki, P Leszek, T Zieliński, T Rywik... - Cardiology ..., 2012 - Background: Based on the results of clinical trials, the prognosis for patients with severe heart failure (HF) has improved over the last 20 years. However, clinical trials do not reflect'real life'due to patient selection. Thus, the aim of the POLKARD-HF registry was the ...
|
|
|
